Destina Genomics

Develops non-enzymatic nucleic acid detection technology

placeEdinburgh, Scotland, United Kingdom calendar_todayFounded 2010 groups2 employees language destinagenomics.com

Registered entities

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace dormant. Cited 2 times.

YearFilings
20181
20191
20201

Social engagement

Social engagement: 1.8K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%

Recent activity

2 Jul 2026
Product launch
LiverAceTM Singleplex
17 Jun 2026
Product launch
LiverAceTM Singleplex
Coming soon